I’m excited to share our new paper in @CellCellPress!
We combine single-cell genomics with programmable, inflammation-sensing CAR T cells to reprogram neuroinflammation in MS.
It was a true team effort, and I’m incredibly grateful for the collaboration, dedication, and support!
1/15 Can we engineer safer, more effective CAR T cells for MS? New in @CellCellPress: we identify pathogenic PD-1⁺ T cells and target them with inflammation-gated CAR T cells that reprogram neuroinflammation. @Rotem_Shalita@mayaby15 Chamutal Gur
https://t.co/hhzGC7VibI
Excited to share two back-to-back studies with @jonykipnis@boskovic_p showing the promise of CAR T beyond cancer — in Alzheimer’s and stroke — inspired by the visionary work of Zelig Eshhar.